Apollo Hospitals will leverage AI for Heart

New Delhi: Apollo Hospitals’ avowed aim of fighting against tsunami of Non Communicable Diseases (NCD) including cardiovascular disease has got a force multiplier in Microsoft. This partnership will lead to the prediction of the risk of cardiovascular disease in the Indian population.

As part of Microsoft’s AI Network for Healthcare initiative, Microsoft India and Apollo Hospitals Group have joined hands to set up a National Clinical Coordination Committee (NCCC) for AI-powered Cardiovascular Disease Risk Score API.

According to a press release NCCC will assist the core team at Apollo Hospitals and Microsoft by providing guidance on all cardiology and cardiovascular-related artificial intelligence projects; insights on developing clinical algorithm and treatment guidelines based on the inferences of national, multi-centre prospective study, a release said here.

‘The NCCC is a great step forward as part of our partnership with Apollo. We are also engaging global consortium partners to scale the AI-powered API (application programme interface),’ Microsoft, Cloud & Enterprise, Corporate Vice President, Anil Bhansali said,

‘We have already received approval for a pilot study and we hope that the findings will enable physicians to better understand the causes of CVDs in Indian population,’ he further said.

Speaking about the National Clinical Coordination Committee, Apollo Hospitals Group, Joint Managing Director, Sangita Reddy, said, ‘The NCCC will help us immensely in our fight against the rising tsunami of Non-Communicable Diseases (NCDs).’

According to the release, cardiovascular diseases (CVDs) are the biggest cause of mortality in India with nearly 25 percent mortalities in the age group of 25 to 69 years. The condition also seems to affect Indians at least a decade earlier as compared to the Europeans.

Given the high prevalence of CVDs among Indians, Apollo Hospitals and Microsoft India, in 2018, launched the first ever AI-powered CVD Risk Score API, designed specifically to predict the risk of cardiovascular disease in the Indian population, it said.

Built on Microsoft Azure, the API aims to determine a more accurate CVD risk score for the Indian population taking into consideration risk factors including lifestyle attribute like diet, tobacco and smoking preferences, physical activity and psychological stress and anxiety.

Related Posts

Aster Quality Care all set to make Advanced Healthcare Ubiquitous in India

Merger between Aster DM and Quality Care India will transcend Metros with 39 Hospitals across 28 cities Bangaluru: The mission is to expand Aster DM’s core brand promise ‘We’ll treat…

Blindness is not God’s wish; Gods are here to prevent it- Entod

Pharma company partners with Dr. Shroff Charity Eye Hospital for Free Cataract Surgeries New Delhi: It is a happy coincidence with Nikhil K Masurkar, CEO of Entod pharma, that his…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Aster Quality Care all set to make Advanced Healthcare Ubiquitous in India

Aster Quality Care all set to make Advanced Healthcare Ubiquitous in India

Rajasthan Bans Common Anaesthesia Injection Batch Used In Caesarean Deliveries And Surgeries: What Patients Need To Know

Rajasthan Bans Common Anaesthesia Injection Batch Used In Caesarean Deliveries And Surgeries: What Patients Need To Know

Raj orders statewide inspection of blood centres for compliance with safety norms

Raj orders statewide inspection of blood centres for compliance with safety norms

mRNA Vaccines Proven Safe And Highly Effective Against Severe Infectious Diseases, Finds Lancet Review

mRNA Vaccines Proven Safe And Highly Effective Against Severe Infectious Diseases, Finds Lancet Review

Telangana bets big on drug discovery hub

Telangana bets big on drug discovery hub

Mankind Pharma joins hands with Denovo Sciences for AI-powered drug discovery

Mankind Pharma joins hands with Denovo Sciences for AI-powered drug discovery